YOOZ Showcases Mini and Energy Series at Vaper Expo UK 2022

Oct.07.2022
YOOZ Showcases Mini and Energy Series at Vaper Expo UK 2022
The Vaper Expo UK 2022 showcased top Chinese e-cigarette brands, including YOOZ and their popular mini and ENERGY series products.

The Vaper Expo UK, a prominent electronic cigarette exhibition, is set to take place from October 7-9, 2022, in the United Kingdom. Among the participants are several Chinese electronic cigarette brands, including the well-known YOOZ brand, showcasing their mini and ENERGY product lines.


Yuzu Booth: Be Yourself and More


The staff members of YOOZ stated that their Mini 1+2 interchangeable cartridge series is their flagship product, with a focus on offering cost-effective solutions. The beginner's kit, which includes one vape pen and two pods, retails for £7.99 and is currently available through major distributors in the UK. During the exhibition, YOOZ Mini was discounted to £5 per kit, and customers could purchase three kits for £10.


Yuzu promotes mini 1+2 cartridge-based product. Possible Translation: Yuzu is promoting a new product that features an interchangeable cartridge system called mini 1+2. The citrus fruit company hopes this innovation will attract more customers and increase sales.


The YOOZ mini, which is available for sale in the UK, has been optimized for local users in terms of flavor. Fruit flavors now have a more pronounced sweetness. According to on-site tests and feedback, men generally prefer the taste of kiwi, while women tend to favor strawberry flavor.


Another interesting product, YOOZ ENERGY, although named "DISPOSABLE" and resembling a disposable product in appearance, still has a replaceable pod design. Each pod contains 2ml and can support up to 1200 puffs. It uses environmentally friendly materials and has a rechargeable battery, catering to the demands of the European market. However, its release status is currently unclear.


For further updates on the latest news regarding the Birmingham Electronic Cigarette Exhibition in the UK, click on the link below.


1. This article is intended solely for internal industry communication and discussion, and does not serve as a promotion or recommendation of any brand or product. 2. Smoking is detrimental to health. Minors are prohibited from reading this article.


This article is an original creation of Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company, and no unit or individual may copy, reprint, or use it in any other way without authorization, violating the company's copyright. Violators will be subject to legal liability.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

InterTabac 2026: First conference program highlights now available online
InterTabac 2026: First conference program highlights now available online
With three months to go before the international tobacco and nicotine industry gathers again in Dortmund, InterTabac, together with NUBIZ and InterSupply, is set to bring around 800 exhibitors from across the globe to eleven exhibition halls. The three events will showcase innovation, market trends and industry networking, while the first conference program highlights are now online, offering trade visitors keynotes, panel discussions and masterclasses to support business decision-making.
Events
Jun.22
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08
 Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
The Washington Examiner published an opinion article by Tricia McLaughlin, former Assistant Secretary for Public Affairs and spokesperson at the U.S. Department of Homeland Security, arguing that the Trump administration is strengthening enforcement against illegal vape supply chains through the FDA, CBP, and DHS.
Regulations
May.25
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italy’s Lazio Regional Administrative Court has dismissed an appeal by Italian Tobacco Manufacturing and Manifattura Italiana Tabacco over the cigarette excise calculation mechanism, upholding the minimum tax burden rules and excluding compensation for smaller tobacco operators.
News
Jun.26 by 2Firsts Perspectives
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26